CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dimension Therapeutics, Inc. (“Dimension” or the “Company”), a rare disease company with a world-class development team advancing novel, liver-directed treatments for diverse genetic disorders based upon an industry-leading AAV gene therapy platform, today announced that Annalisa Jenkins, MBBS, MRCP, President and Chief Executive Officer, will present a corporate overview at the 22nd Annual Future Leaders in the Biotech Industry Conference on Friday, March 20, 2015, at 10:30 a.m. Eastern Time.
Help employers find you! Check out all the jobs and post your resume.
